Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
European Journal of Human Genetics : EJHG|January 31, 2013
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder eventsStefan Aretz, Rossella Tricarico, Laura Papi, et al.Frontiers in Immunology|May 20, 2021
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory DiseasesNastya Kharlamova, Nicky Dunn, Sahl K Bedri, et al.Leukemia|September 26, 2021
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patientsLisa Blixt, Gordana Bogdanovic, Marcus Buggert, et al.Cancers|January 21, 2022
Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal FluidPablo Juanes-Velasco, Norma Galicia, Elisa Pin, et al.Journal of Proteome Research|October 11, 2021
Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody BiomarkersPablo San Segundo-Acosta, Ana Montero-Calle, August Jernbom-Falk, et al.Frontiers in Immunology|January 27, 2023
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIVMahin Ghorbani, Khaled Al-Manei, Sabrina Naud, et al.Journal of Proteome Research|December 8, 2022
Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome ProjectManuel Fuentes, Cristina Ruiz-Romero, Sara Misiego, et al.Scientific Reports|March 5, 2021
Antibodies to SARS-CoV-2 and risk of past or future sick leaveJoakim Dillner, K Miriam Elfström, Jonas Blomqvist, et al.Nature Communications|October 9, 2020
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in SwedenAnn-Sofie Rudberg, Sebastian Havervall, Anna Månberg, et al.Plos One|January 12, 2022
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSebastian Havervall, August Jernbom Falk, Jonas Klingström, et al.Pageof 5